Nano Bugle

A window into applied science supported by INL

Nanotechnology in the healthcare sector

In an interview published in PharmTech, four specialists give their opinion on the contribution of Nanotechnology in the healthcare sector. It become clear that a lot as been done, but even more is yet to be achieved.

Professor Jamie C. Oliver, President & CEO, Peptagen; Adriana Vela, Founder and CEO, NanoTecNexus; Dr Gary Liversidge, Chief Technology Officer, Elan Drug Technologies and Professor Mike Eaton Executive Board Member, European Technology Platform on Nanomedicines answer the following questions: ‘What has been nanotechnology’s greatest contribution to the healthcare sector in the last 5 years?’, ‘What challenges does nanotechnology pose to the pharma industry?’, ‘Will pharmaceutical manufacturing processes need to be adapted in any way to work with nanomaterials?’, ‘How do you think nanomedicines will be regulated in the future?’ and ‘What future advances in nanotechnology do you think will have a significant impact on the pharma and biopharma industries?’


March 2, 2010 - Posted by | Nanomedicine


  1. Nanotechnology is changing the face of medicine and other fields. We live in an age where the lines between computer support and human support are blurring.

    Comment by Amy | April 13, 2010 | Reply

  2. Great article. Insightful and entertaining as always!

    Comment by acai order | August 27, 2010 | Reply

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: